Psychopharmacology Publishes Combined Analysis of Phase 2 Clinical Trials of MDMA-Assisted Psychotherapy for PTSD
Today, the overall results of six Phase 2 clinical trials of MDMA-assisted psychotherapy for the treatment of posttraumatic stress disorder (PTSD) were published in the peer-reviewed journal Psychopharmacology. The paper is the most comprehensive analysis yet published of research into the efficacy and safety of MDMA-assisted psychotherapy for PTSD.
Five sites in California, Colorado, Louisiana, and South Carolina now open for enrollment inquiries, with more opening soon. All-new video—Breakthrough for Psychedelic Medicine—explains how individuals can support non-profit research for PTSD and other mental health conditions